Nanologica AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.941 million compared to SEK 2.2 million a year ago. Net loss was SEK 36.84 million compared to SEK 14.86 million a year ago. Basic loss per share from continuing operations was SEK 1.02 compared to SEK 0.42 a year ago.
For the full year, sales was SEK 4.67 million compared to SEK 5.83 million a year ago. Net loss was SEK 75.16 million compared to SEK 55.23 million a year ago. Basic loss per share from continuing operations was SEK 2.08 compared to SEK 1.84 a year ago.